The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...

Symptoms of viruses like COVID and flu overlap with each other, but there are ways you can narrow it down to get the ...

Some of these airborne particles, such as pollen, pet dander and mold spores, are irritants that can aggravate people's allergies. These particles can make their way into our bodies as we breathe ...

If seasonal allergies are turning your eyeballs to sandpaper and your nostrils to leaky faucets, you’re not alone. Temperatures in the Chicago area have been unusually mild this fall ...

Every time she visits, she insists on bringing the dog, even though her sister is allergic to dogs, especially breeds like retrievers. The visits have become increasingly uncomfortable for my ...

Federal officials have celebrated a striking drop in drug overdoses across the country. But state-level data shows that Black people are suffering significantly worse outcomes than white people.

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary ...

The drug Donanemab has been found to slow the progression of Alzheimer’s disease. Despite this is has been rejected for widespread use in the health service in England after the health spending ...

A new medically challenging case warns that, for those with allergies and asthma, health problems from burning incense can be a significant risk to adults and children. In many cultures ...

On X recently, Eric Topol, a cardiologist who leads Scripps Research, a non-profit research institute in San Diego, California, called GLP-1 drugs “the most important drug-class breakthrough in ...

A pioneering new drug, which has been shown to slow the advance of Alzheimer's, will not be available to patients on the NHS as Ian Woods reports. A new "effective" Alzheimer's drug has been ...